YM543 is a novel selective inhibitor of the sodium-glucose cotransporter 2. The objectives of the current study were to evaluate the utility of mice with humanized livers to predict human drug metabolites using YM543 as a case example.
13 February 2017
Pharmaceutical research
Authors: Naoyuki Nakada
Contact us to find out how the PhoenixBio team could help your projects.